109 related articles for article (PubMed ID: 7186819)
1. Effects of 5-hydroxytryptamine on canine isolated coronary arteries.
Porquet MF; Pourrias B; Santamaria R
Br J Pharmacol; 1982 Feb; 75(2):305-10. PubMed ID: 7186819
[TBL] [Abstract][Full Text] [Related]
2. On the mode of action of ergometrine in the isolated dog coronary artery.
Sakanashi M; Yonemura KI
Eur J Pharmacol; 1980 Jun; 64(2-3):157-60. PubMed ID: 7398759
[TBL] [Abstract][Full Text] [Related]
3. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
4. Importance of magnesium and potassium concentration on basal tone and 5-HT-induced contractions in canine isolated coronary artery.
Murakawa T; Altura BT; Carella A; Altura BM
Br J Pharmacol; 1988 Jun; 94(2):325-34. PubMed ID: 3395781
[TBL] [Abstract][Full Text] [Related]
5. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Cocks TM; Kemp BK; Pruneau D; Angus JA
Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
[TBL] [Abstract][Full Text] [Related]
6. Responses of isolated canine intermediate auricular arteries to 5-hydroxytryptamine and methysergide.
Ito T; Chiba S
Eur J Pharmacol; 1984 Sep; 104(1-2):105-9. PubMed ID: 6499909
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of lidoflazine on contractions of isolated canine coronary arteries caused by norepinephrine, 5-hydroxytryptamine, high potassium, anoxia and ergonovine maleate.
Van Neuten JM; Van Beek J; Vanhoutte PM
J Pharmacol Exp Ther; 1980 Apr; 213(1):179-87. PubMed ID: 7359366
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of ergometrine-induced coronary arterial spasm: in vitro studies on canine arteries.
Müller-Schweinitzer E
J Cardiovasc Pharmacol; 1980; 2(5):645-55. PubMed ID: 6157956
[TBL] [Abstract][Full Text] [Related]
9. Vasoconstrictor mechanism of 5-hydroxytryptamine in isolated and perfused canine basilar arteries.
Tsuji T; Chiba S
Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):111-22. PubMed ID: 3592852
[TBL] [Abstract][Full Text] [Related]
10. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.
Apperley E; Humphrey PP; Levy GP
Br J Pharmacol; 1976 Oct; 58(2):211-21. PubMed ID: 184872
[TBL] [Abstract][Full Text] [Related]
11. Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors.
Brazenor RM; Angus JA
J Pharmacol Exp Ther; 1981 Aug; 218(2):530-6. PubMed ID: 6114172
[TBL] [Abstract][Full Text] [Related]
12. Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs.
Woodman OL
Br J Pharmacol; 1990 May; 100(1):153-7. PubMed ID: 2372656
[TBL] [Abstract][Full Text] [Related]
13. Depressant effect of trapidil on dog coronary arterial contraction induced by ergonovine.
Sakanashi M; Yoshikawa Y; Kondoh G; Yonemura K
Jpn Heart J; 1981 May; 22(3):413-9. PubMed ID: 7265467
[TBL] [Abstract][Full Text] [Related]
14. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
Cohen RA
J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of ergonovine on isolated porcine coronary artery: the role of Ca2+.
Rosenberger LB; Griffin MA; Stanton HC
Can J Physiol Pharmacol; 1983 Jul; 61(7):685-92. PubMed ID: 6616330
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in the response to vasoconstrictor agents of dog and monkey isolated coronary arteries.
Miwa K; Toda N
Br J Pharmacol; 1984 May; 82(1):295-301. PubMed ID: 6587928
[TBL] [Abstract][Full Text] [Related]
17. Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries.
Marin J; Salaices M; Gómez B; Lluch S
J Pharm Pharmacol; 1981 Nov; 33(11):715-9. PubMed ID: 6118410
[TBL] [Abstract][Full Text] [Related]
18. A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein.
Watts AD; Feniuk W; Humphrey PP
J Pharm Pharmacol; 1981 Aug; 33(8):515-20. PubMed ID: 6115926
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal of magnesium enhances coronary arterial spasms produced by vasoactive agents.
Altura BM; Turlapaty PD
Br J Pharmacol; 1982 Dec; 77(4):649-59. PubMed ID: 7150872
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of noradrenaline and serotonin in a central and a peripheral artery in vitro.
Tayo FM
Afr J Med Med Sci; 1983; 12(3-4):139-43. PubMed ID: 6326547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
